Eli Lilly’s Global CEO David Ricks revealed that the pharma giant might manufacture its weight-loss blockbuster, Mounjaro, in ...

Ozempic, the Danish pharma giant Novo Nordisk's anti-diabetic drug, has had everyone's attention over the past year. The ...

Eli Lilly has launched its diabetes and weight-loss drug Mounjaro in India, marking its entry into a rapidly growing market.

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, ...

Widely used prescription medicines could get caught up in the Trump administration's tariff trade wars and EU retaliation.

Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.

We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best quality stocks ...

SHANGHAI (Reuters) -Eli Lilly said on Tuesday its diabetes drug tirzepatide has received approval from Chinese regulators,... INDIANAPOLIS - Eli Lilly and Company (NYSE:LLY) announced successful ...

“I do my blessings and everything that I need to pray or whatever, and then I work out,” said Hernandez, executive vice president at Eli Lilly and Co. and president of manufacturing operation ...

Compared to last year’s predictions, Eli Lilly’s Type 2 diabetes drug Mounjaro joined the top 10 list and secured the third spot with projected sales of nearly $20 billion. The three other GLP ...

Cristina Arias / Cover / Getty Images Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly ... and Wegovy and Lilly's Mounjaro and Zepbound.